Package 62175-572-37

Brand: verelan pm

Generic: verapamil hydrochloride
NDC Package

Package Facts

Identity

Package NDC 62175-572-37
Digits Only 6217557237
Product NDC 62175-572
Product ID 62175-572_465f8a37-f736-4a2e-9dbe-ef0a124b0f0e
Description

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62175-572-37)

Marketing

Marketing Status
Marketed Since 1998-11-25
Brand verelan pm
Generic verapamil hydrochloride
Sample Package No

Linked Drug Pages (1)

VERELAN PM ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "465f8a37-f736-4a2e-9dbe-ef0a124b0f0e", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897584", "897586", "897590", "897592", "897596", "897598"], "spl_set_id": ["fd1b433f-1895-4af0-9d1f-3901c6d34c20"], "manufacturer_name": ["Lannett Company, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62175-572-37)", "package_ndc": "62175-572-37", "marketing_start_date": "19981125"}], "brand_name": "VERELAN PM", "product_id": "62175-572_465f8a37-f736-4a2e-9dbe-ef0a124b0f0e", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "62175-572", "generic_name": "verapamil hydrochloride", "labeler_name": "Lannett Company, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERELAN PM", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "NDA020943", "marketing_category": "NDA", "marketing_start_date": "19981125", "listing_expiration_date": "20261231"}